Cargando…
siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588511/ http://dx.doi.org/10.1093/nar/gkn882 |
_version_ | 1782160942001291264 |
---|---|
author | de Martimprey, Henri Bertrand, Jean-Remi Fusco, Alfredo Santoro, Massimo Couvreur, Patrick Vauthier, Christine Malvy, Claude |
author_facet | de Martimprey, Henri Bertrand, Jean-Remi Fusco, Alfredo Santoro, Massimo Couvreur, Patrick Vauthier, Christine Malvy, Claude |
author_sort | de Martimprey, Henri |
collection | PubMed |
description | |
format | Text |
id | pubmed-2588511 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-25885112009-03-04 siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma de Martimprey, Henri Bertrand, Jean-Remi Fusco, Alfredo Santoro, Massimo Couvreur, Patrick Vauthier, Christine Malvy, Claude Nucleic Acids Res Corrigendum Oxford University Press 2008-12 2008-11-25 /pmc/articles/PMC2588511/ http://dx.doi.org/10.1093/nar/gkn882 Text en © 2008 The Author(s) http://creativecommons.org/licenses/by-nc/2.0/uk/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Corrigendum de Martimprey, Henri Bertrand, Jean-Remi Fusco, Alfredo Santoro, Massimo Couvreur, Patrick Vauthier, Christine Malvy, Claude siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma |
title | siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma |
title_full | siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma |
title_fullStr | siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma |
title_full_unstemmed | siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma |
title_short | siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma |
title_sort | sirna nanoformulation against the ret/ptc1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588511/ http://dx.doi.org/10.1093/nar/gkn882 |
work_keys_str_mv | AT demartimpreyhenri sirnananoformulationagainsttheretptc1junctiononcogeneisefficientinaninvivomodelofpapillarythyroidcarcinoma AT bertrandjeanremi sirnananoformulationagainsttheretptc1junctiononcogeneisefficientinaninvivomodelofpapillarythyroidcarcinoma AT fuscoalfredo sirnananoformulationagainsttheretptc1junctiononcogeneisefficientinaninvivomodelofpapillarythyroidcarcinoma AT santoromassimo sirnananoformulationagainsttheretptc1junctiononcogeneisefficientinaninvivomodelofpapillarythyroidcarcinoma AT couvreurpatrick sirnananoformulationagainsttheretptc1junctiononcogeneisefficientinaninvivomodelofpapillarythyroidcarcinoma AT vauthierchristine sirnananoformulationagainsttheretptc1junctiononcogeneisefficientinaninvivomodelofpapillarythyroidcarcinoma AT malvyclaude sirnananoformulationagainsttheretptc1junctiononcogeneisefficientinaninvivomodelofpapillarythyroidcarcinoma |